REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,689 | -54.7% | 18,020 | 0.0% | 0.01% | -38.9% |
| Q2 2023 | $456,086 | -21.4% | 18,020 | 0.0% | 0.02% | -30.8% |
| Q1 2023 | $580,424 | +74.5% | 18,020 | 0.0% | 0.03% | +73.3% |
| Q4 2022 | $332,649 | -59.3% | 18,020 | -40.4% | 0.02% | -59.5% |
| Q3 2022 | $817,000 | +95.5% | 30,256 | 0.0% | 0.04% | +131.2% |
| Q2 2022 | $418,000 | -27.7% | 30,256 | +2.0% | 0.02% | -30.4% |
| Q1 2022 | $578,000 | +19.4% | 29,657 | 0.0% | 0.02% | +15.0% |
| Q4 2021 | $484,000 | -40.7% | 29,657 | +1.3% | 0.02% | -51.2% |
| Q3 2021 | $816,000 | -6.0% | 29,274 | 0.0% | 0.04% | -6.8% |
| Q2 2021 | $868,000 | +6.1% | 29,274 | 0.0% | 0.04% | 0.0% |
| Q1 2021 | $818,000 | -99.9% | 29,274 | 0.0% | 0.04% | -8.3% |
| Q4 2020 | $829,625,000 | – | 29,274 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |